Igm Biosciences
California, United States
201-500 Employees
Automotive
•Healthcare
•Tech
Clinical Biomarker Scientist, Immunology (temporary)
Doylestown, Pennsylvania, --
Description
IGM Biosciences (NASDAQ: IGMS) is a leading biotechnology company dedicated to developing innovative immunotherapies for the treatment of cancer. Founded in 2010, IGM Biosciences is at the forefront of leveraging cutting-edge technologies to engineer novel IgM antibodies that can target cancer cells with precision. With a focus on advancing next-generation immunotherapies, IGM Biosciences is revolutionizing the field of oncology and striving to improve outcomes for cancer patients worldwide.
Financials
Type
public
Annual Revenue
--
Market Cap
$75.3M+
Subscribe to Refer Me premium to get referred to this role at Igm Biosciences!